Elisabeth Leiderman
Director/Board Member at BLUEBIRD BIO, INC.
Net worth: 20 320 $ as of 2024-04-29
Elisabeth Leiderman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Director/Board Member | 2021-10-14 | - |
| Independent Dir/Board Member | 2021-10-14 | - | |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 2023-12-19 | - |
Career history of Elisabeth Leiderman
Former positions of Elisabeth Leiderman
| Companies | Position | Start | End |
|---|---|---|---|
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Director of Finance/CFO | 2022-11-06 | 2023-10-31 |
| DECIBEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2021-09-08 | 2022-10-06 |
| Director of Finance/CFO | 2020-08-31 | 2022-10-06 | |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Corporate Officer/Principal | 2016-10-31 | 2020-07-31 |
| Nomura Securities, Inc. | Director/Board Member | 2012-12-31 | 2016-06-30 |
| FORTRESS BIOTECH, INC. | Corporate Officer/Principal | 2006-12-31 | 2015-12-31 |
Training of Elisabeth Leiderman
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Sackler School of Medicine | Doctorate Degree |
Statistics
International
| United States | 9 |
| Israel | 2 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private companies | 3 |
|---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
| Nomura Securities, Inc. | |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Elisabeth Leiderman
- Experience